Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis.
about
Managing Patients With Myelofibrosis in the Era of Janus Kinase InhibitorsGroup 5 Pulmonary Hypertension: The Orphan's Orphan Disease.Ruxolitinib: long-term management of patients with myelofibrosis and future directions in the treatment of myeloproliferative neoplasmsPulmonary extra-medullary hematopoiesis and pulmonary hypertension from underlying polycythemia vera: a case series.Efficacy and safety of ruxolitinib in the treatment of patients with myelofibrosis.Pulmonary Hypertension Associated with Pulmonary Veno-occlusive Disease in Patients with Polycythemia Vera.Fasudil, a clinically safe ROCK inhibitor, decreases disease burden in a Cbl/Cbl-b deficiency-driven murine model of myeloproliferative disorders.Resolution of myelofibrosis-associated pulmonary arterial hypertension following allogeneic hematopoietic stem cell transplantationPulmonary arterial hypertension exacerbated by ruxolitinib.Medical Management of Pulmonary Hypertension with Unclear and/or Multifactorial Mechanisms (Group 5): Is There a Role for Pulmonary Arterial Hypertension Medications?A case-based discussion of clinical problems in the management of patients treated with ruxolitinib for myelofibrosis.
P2860
Q28073296-7B523380-160A-4E03-BD5E-1F67CEF65351Q30248872-C8371626-E13C-4782-9B86-59719E086D74Q33417217-4DB032B8-85B3-4D90-AF3A-5DFB158C3762Q33738626-38B8520C-D18D-47B9-AB8F-8E221CABC108Q37035925-EB66C135-98AD-404A-87D0-6CC46905BF51Q38616947-95772C88-D35E-4518-AEA7-96E60F688A56Q41378115-77B2EE7A-FE65-421F-ACE0-C23A0B1497F8Q42111169-59A32AAB-71BE-4394-A03F-E06D60DD219FQ42847687-E629FBD5-3131-440A-91EE-10E8815F2E17Q50092007-DD13026B-0C03-47E6-8E82-1DB6869155BCQ51111145-B4E6C3F0-F33F-4661-8150-F3A1C751372E
P2860
Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Ruxolitinib leads to improveme ...... n patients with myelofibrosis.
@en
Ruxolitinib leads to improveme ...... n patients with myelofibrosis.
@nl
type
label
Ruxolitinib leads to improveme ...... n patients with myelofibrosis.
@en
Ruxolitinib leads to improveme ...... n patients with myelofibrosis.
@nl
prefLabel
Ruxolitinib leads to improveme ...... n patients with myelofibrosis.
@en
Ruxolitinib leads to improveme ...... n patients with myelofibrosis.
@nl
P2093
P2860
P356
P1433
P1476
Ruxolitinib leads to improveme ...... n patients with myelofibrosis.
@en
P2093
A Tabarroki
D J Lindner
G A Heresi
H J Rogers
M A Sekeres
M E Kalaycio
P2860
P2888
P304
P356
10.1038/LEU.2014.5
P577
2014-01-10T00:00:00Z
P6179
1032437501